Clinical Trials Sponsored by Bioneer Corporation

Total 6533 results

Bionor Immuno AS
Celgene Corporation

Completed

Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART) (IMID)

HIV-1 Infection

Germany
Bionor Immuno AS
Celgene Corporation

Completed

Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir (REDUC)

HIV I Infection

Denmark
Bioness Inc
Bioness Neuromodulation

Completed

Evaluation of the Safety and Performance of the NESS L300 Plus System (L300Plus)

Foot Drop | Thigh Muscles Weakness (Hamstrings or Quadriceps) | Upper Motor Neuron Injury or Disease

Israel
Pioneer Surgical Technology, Inc.

Completed

Assessment of nanOss Bioactive 3D in the Posterolateral Spine

Degenerative Disc Disease | Spinal Stenosis | Spondylolisthesis

United States
Pioneer Surgical Technology, Inc.

Terminated

Post-Market Study Evaluating the Safety and Effectiveness of NuNec® Cervical Arthroplasty System

Cervical Intervertebral Disc Degeneration

United Kingdom
Pioneer Surgical Technology, Inc.

Completed

Comparison of nanOss Bioactive With Autograft and Bone Marrow Aspirate to Autograft in the Posterolateral Spine

Degenerative Disc Disease | Spinal Stenosis | Spondylolisthesis

United States
Pioneer Surgical Technology, Inc.

Terminated

Effectiveness of Lumbar Fusion When NanOss Bioactive Is Used With Posterolateral Gutter Fusions

Degenerative Disc Disease | Spinal Stenosis | Spondylolisthesis

United States
Pioneer Surgical Technology, Inc.

Completed

Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty

Degenerative Disc Disease

United States
BioKier Inc.

Completed

Dose-Response Study to Evaluate the Effect of BKR-017 on Insulin Resistance and Other Metabolic Parameters in Type 2 Diabetes Patients

Type 2 Diabetes

United States
Bioster, a.s.

Completed

Traumacel FAM Trium in the Post-market Surveillance Phase

Bleeding | Surgical Wound

Czechia
Bioness Inc

Completed

Bioness® StimRouter™ Neuromodulation System for Chronic Pain Therapy

Chronic Pain

United States
Bioness Inc

Completed

An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects (BBPM)

Shoulder Pain Chronic

United States
Bioness Neuromodulation
Loewenstein Hospital; Bioness Inc

Unknown

Evaluation of Usability and Human Factors in the Novus System

Muscle Weakness | Motor Neuron Disease, Upper | Drop Foot

Israel
Bioness Inc

Completed

Acute Human Study: StimRouter for Peripheral Nerve Stimulation of Discrete Peripheral Nerves (StimRouter)

Unilateral Carpal Tunnel Syndrome

United States
Pioneer Surgical Technology, Inc.

Withdrawn

NanOss Bioactive With Autograft and Bone Marrow Aspirate in the Posterolateral Spine

Lumbar Spinal Stenosis Secondary to Other Disease
Bioness Inc

Recruiting

StimRouter Registry Clinical Protocol

Nervous System Diseases | Chronic Pain | Peripheral Nervous System Diseases | Peripheral Neuropathy | Peripheral Nerve Injuries | Peripheral Nervous System Problem | Peripheral Nervous

United States
Bioster, a.s.

Completed

Traumacel PULVIS and Traumacel ENDO Applicator in the Post-market Surveillance Phase

Bleeding | Surgical Wound

Czechia
Bioness Inc

Unknown

Overactive Bladder Treatment Using StimRouter Neuromodulation System: A Prospective Randomized Trial

Overactive Bladder

United States, Canada
Bioness Inc

Terminated

StimRouter™ for Pain Management in Post-stroke Shoulder Pain (PSSP)

Chronic Pain | Hemiplegic Shoulder Pain

United States
BioKier Inc.

Completed

Effects of BKR-017 on Insulin Resistance in Type 2 Diabetes Patients

Type 2 Diabetes

United States
Bionor Immuno AS

Completed

Re-boosting of HIV-1 Infected Subjects With Vacc-4x (Re-boost)

HIV-1 Infection

United States, Spain, Germany, Italy, United Kingdom
Bioness Neuromodulation
Loewenstein Hospital

Completed

Evaluation of Dual Channel vs. Single Channel FES for Dropfoot

Dropfoot

Israel
Bionor Immuno AS

Completed

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

HIV I Infection

Germany, United States, Spain, United Kingdom, Italy
Bionor Immuno AS

Completed

Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART

HIV-1 Infection

Norway
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
Darell Bigner

Completed

D2C7 for Adult Patients With Recurrent Malignant Glioma

Malignant Glioma | Brain Tumor, Recurrent

United States
Foundation for Innovative New Diagnostics, Switzerland
Universidad Peruana Cayetano Heredia; Kenya Medical Research Institute; V. N.... and other collaborators

Active, not recruiting

Bioneer IRONqPCR ™ RFIA Kit Kit Clinical Evaluation

Tuberculosis, Multidrug-Resistant

Kenya, Peru, Ukraine
Darell Bigner
Rockefeller University

Not yet recruiting

D2C7-IT + 2141-V11 Combination Post-rection in rGBM - Phase 1b

Recurrent Glioblastoma IDH Wildtype

United States
Darell Bigner
Rockefeller University

Recruiting

D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Newly Diagnosed MGMT Unmethylated Glioblastoma

United States
Mahidol University
BioNet-Asia Co., Ltd.

Completed

5-year Follow-up After a Single Dose Acellular Pertussis Vaccination

Pertussis

Thailand
Jaap Bonjer

Unknown

COLOR II: Laparoscopic Versus Open Rectal Cancer Removal (COLORII)

Rectal Cancer

Netherlands, Sweden, Spain, Korea, Republic of, Belgium, Canada, Denmark, Germany, Poland
Bioness Inc
University of Cincinnati; Medidata Solutions

Completed

Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop (L300)

Gait, Drop Foot | Sensorimotor Gait Disorder | Neurologic Ambulation Disorder | Poststroke Hemiparesis | Post-Cerebrovascular Accident (CVA) Hemiparesis

United States
Darell Bigner
Rockefeller University

Recruiting

Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

Glioma, Malignant

United States
Mayo Clinic
Juvenile Diabetes Research Foundation; BioKier Inc.

Recruiting

Butyrate Adjuvant Therapy for Type 1 Diabetes

Type1diabetes

United States
Darell Bigner
Istari Oncology, Inc.

Not yet recruiting

Lerapolturev (PVSRIPO) in GBM

Recurrent Supratentorial Glioblastoma

United States
Centre Francois Baclesse, Luxembourg
BIONEXT; NEOLYS DIAGNOSTICS - ALARA GROUP

Not yet recruiting

Pre-therapeutic Analysis of the Individual Radiosensitivity of Cancer Patients in Luxembourg (APRI-Lux): Prospective National Interventional Study With Minimal Risk

Cancer | Radiation Toxicity | Radiosensitivity
Rgene Corporation
American BriVision Corporation

Not yet recruiting

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Nonsquamous Nonsmall Cell Neoplasm of Lung

Taiwan
Rgene Corporation
American BriVision Corporation

Not yet recruiting

A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

Pancreatic Cancer
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA Modul 7 VRR

Atrial Fibrillation

Germany
Boston Scientific Corporation
EKOS Corporation

Completed

ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism (ULTIMA)

Submassive Pulmonary Embolism

Germany, Switzerland
Boston Scientific Corporation
EKOS Corporation

Completed

Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism (OPTALYSE PE)

Pulmonary Embolism and Thrombosis

United States, United Kingdom
Boston Scientific Corporation
EKOS Corporation

Completed

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy (SEATTLE II)

Pulmonary Embolism | Acute Pulmonary Embolism | Pulmonary Thromboembolism | Massive Pulmonary Embolism | Sub-massive Pulmonary Embolism

United States
Boston Scientific Corporation
Guidant Corporation

Completed

MODULA Modul 5 BEAT-HF

Heart Failure

Germany
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms

Heart Failure

Germany
Guidant Corporation
Boston Scientific Corporation

Completed

Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following (Cogent-4)

Heart Failure | Ventricular Tachycardia, Ventricular Fibrillation

Israel, Denmark
Boston Scientific Corporation
Guidant Corporation

Completed

Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead

Ventricular Fibrillation | Ventricular Tachycardia

France
Boston Scientific Corporation
Guidant Corporation

Completed

Shockless Implant Evaluation (SIMPLE)

Ventricular Fibrillation | Ventricular Tachycardia

Germany, Spain, Canada, Israel, Netherlands, France, Finland, United Kingdom, Austria, Malaysia, Thailand, Hong Kong, Sweden, Hungary, Australia, Czechia, Norway, Poland
Boston Scientific Corporation
Guidant Corporation

Completed

Feature Assessment Study for Indications Based Programming (FASt-IBP)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Flutter

Germany, Spain, Switzerland, China, Austria, Belgium, France, Greece, Latvia, Netherlands, Slovakia
Boston Scientific Corporation
Guidant Corporation

Completed

Japanese Assessment of Indication Based Programming (JASMINE)

Heart Failure | Arrhythmias, Cardiac

Japan
Boston Scientific Corporation
Guidant Corporation

Completed

Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ? (Quick ICD)

Cardiac Arrest

Germany

Clinical Trials Sponsored by Bioneer Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations